[1]
LuanP. V., TienN. D., HaiN. M., TienN. D., và DuyenT. T., “Real-world analysis of the effect of gefitinib as a first-line therapy in patients with advanced non-small cell lung cancer with EGFR mutations”, YDLS, vol 15, số p.h TA, tháng 4 2021.